1 00:00:00,240 --> 00:00:07,960 Foreign welcome back to Translating Proteomics. 2 00:00:07,960 --> 00:00:12,080 Today I am delighted to welcome Dr. Jennifer Geddes McAllister, 3 00:00:12,080 --> 00:00:14,920 who's an associate professor in the Department of Molecular and 4 00:00:14,920 --> 00:00:17,760 Cellular Biology at the University of Guelph in Ontario, 5 00:00:18,000 --> 00:00:18,400 Canada. 6 00:00:19,280 --> 00:00:23,040 Professor Geddes McAllister did her master's work with Brent 7 00:00:23,120 --> 00:00:26,480 Selinger at the University of Lethbridge, her PhD with Jim Cronstad 8 00:00:26,480 --> 00:00:30,050 at the University of British Columbia, Columbia, and her postdoc 9 00:00:30,050 --> 00:00:33,050 with Matthias Mann at the Max Planck Institute of Biochemistry. 10 00:00:33,450 --> 00:00:37,490 She is a leader in applying proteomics and systems biology techniques 11 00:00:37,490 --> 00:00:41,730 to understand host pathogen interactions and is a strong voice 12 00:00:41,730 --> 00:00:43,290 for moms and proteomics. 13 00:00:44,330 --> 00:00:47,890 Some of Professor Geddes McAllister's recent work focuses 14 00:00:47,890 --> 00:00:51,770 on how we can expand crop productivity and human health by 15 00:00:51,770 --> 00:00:55,450 better understanding the dynamics of fungal disease and resistance. 16 00:00:56,020 --> 00:00:59,820 In a similar vein, her lab is leveraging proteomics and systems 17 00:00:59,820 --> 00:01:03,580 biology to learn how we can engineer plants to efficiently produce 18 00:01:03,580 --> 00:01:05,940 small molecules used to treat human disease. 19 00:01:06,260 --> 00:01:10,500 This is a fascinating field of molecular farming. 20 00:01:11,220 --> 00:01:13,060 That's farming with aph. 21 00:01:14,180 --> 00:01:17,060 And I'm speaking with Jennifer just before we get to see each other 22 00:01:17,060 --> 00:01:21,100 in person at the Human Proteome Organization's 2025 conference 23 00:01:21,100 --> 00:01:21,940 in Toronto. 24 00:01:22,740 --> 00:01:27,040 I'm, I'm sure we're both very excited to connect with researchers 25 00:01:27,040 --> 00:01:29,840 of all types and backgrounds and learn how the field's advanced 26 00:01:29,840 --> 00:01:30,760 in the past year. 27 00:01:31,400 --> 00:01:35,200 Jennifer, thank you so much for joining us and welcome to Translating 28 00:01:35,200 --> 00:01:35,960 Proteomics. 29 00:01:36,440 --> 00:01:37,720 Yeah, thanks for having me. 30 00:01:37,800 --> 00:01:38,840 I'm super excited. 31 00:01:39,080 --> 00:01:40,720 There's so many fun things to chat about. 32 00:01:40,720 --> 00:01:45,640 I'd like to start off by going back in time and understanding a 33 00:01:45,640 --> 00:01:49,480 little bit about how you got interested in host pathogen interactions 34 00:01:49,560 --> 00:01:50,520 in the first place. 35 00:01:51,580 --> 00:01:52,060 For sure. 36 00:01:52,380 --> 00:01:56,820 I, during my undergrad I was doing biochemistry and with a heavy 37 00:01:56,820 --> 00:02:00,380 lean towards biology and started working at the Agriculture 38 00:02:00,380 --> 00:02:03,780 Agriculture and Agri Food Canada Research center, which was 39 00:02:03,780 --> 00:02:08,100 really very much focused on crop improvement, food quality, food 40 00:02:08,100 --> 00:02:08,620 safety. 41 00:02:08,940 --> 00:02:12,860 And I was working on fungal pathogens, which I always found very 42 00:02:12,860 --> 00:02:16,540 fascinating because a lot of work is on bacterial pathogens. 43 00:02:16,860 --> 00:02:20,780 A lot of at that time, it wasn't that long ago, but long enough. 44 00:02:20,860 --> 00:02:23,750 A lot of kits and things that were all designed for bacterial work 45 00:02:23,750 --> 00:02:24,750 and not fungal work. 46 00:02:25,070 --> 00:02:27,070 So I just really love the challenge of it. 47 00:02:27,150 --> 00:02:30,870 And that's when I first started doing proteomics and really 48 00:02:30,870 --> 00:02:33,950 starting to look at things differently. 49 00:02:33,950 --> 00:02:36,470 So what makes pathogen a pathogen? 50 00:02:36,470 --> 00:02:38,910 Why is it infecting a cereal crop? 51 00:02:39,790 --> 00:02:41,790 How is the crop defending itself? 52 00:02:41,790 --> 00:02:44,830 All those dynamics I found just very fascinating. 53 00:02:45,470 --> 00:02:46,550 That's really interesting. 54 00:02:46,550 --> 00:02:47,630 So you're Right. 55 00:02:47,630 --> 00:02:52,510 I mean, my own background, I started studying first a very esoteric 56 00:02:52,510 --> 00:02:56,210 bacteria called Pyrobaculum erophyllum, and then moved into studying 57 00:02:56,210 --> 00:02:59,290 pathogens like tuberculosis and Leishmania. 58 00:02:59,370 --> 00:03:04,410 But the interactions between the pathogen and human, or the pathogen 59 00:03:04,410 --> 00:03:08,170 and plant, that seems like an incredibly. 60 00:03:08,410 --> 00:03:08,770 Like. 61 00:03:08,770 --> 00:03:10,570 Studying the pathogen alone is hard. 62 00:03:10,970 --> 00:03:12,570 Studying the human alone is hard. 63 00:03:12,570 --> 00:03:18,330 Studying the two together seems like just incredibly, incredibly 64 00:03:18,330 --> 00:03:18,890 challenging. 65 00:03:18,890 --> 00:03:23,680 And so was that part of what was exciting to you was just the 66 00:03:24,160 --> 00:03:25,280 extreme unknown? 67 00:03:25,680 --> 00:03:29,640 I think so, I think for sure, because you can understand one side 68 00:03:29,640 --> 00:03:32,320 and understand, we know infection occurs, we know disease 69 00:03:32,320 --> 00:03:32,800 occurs. 70 00:03:33,280 --> 00:03:37,600 And during my PhD, I studied the pathogen and I really focused 71 00:03:37,600 --> 00:03:39,680 on that and how it adapts to its environment. 72 00:03:40,400 --> 00:03:44,000 And then during my postdoc, I was in a systems immunology subgroup. 73 00:03:44,000 --> 00:03:47,600 And so that really started to bring about the host side of things. 74 00:03:48,080 --> 00:03:50,640 And whether it be in a crop or in a. 75 00:03:51,560 --> 00:03:55,160 A host, like a human host, the concepts are very similar. 76 00:03:55,240 --> 00:03:58,200 You have your innate defenses, you have your adaptive defenses, 77 00:03:58,760 --> 00:04:00,600 all sorts of mechanisms at play. 78 00:04:00,680 --> 00:04:04,440 And I think gaining that new knowledge of immunology and kind 79 00:04:04,440 --> 00:04:07,160 of being empowered to understand the host perspective, 80 00:04:08,120 --> 00:04:11,520 that's what really, like, led me to get to where I am now, looking 81 00:04:11,520 --> 00:04:13,160 at both the host and pathogen. 82 00:04:13,560 --> 00:04:15,800 And you're absolutely right, one of them is challenging, so two 83 00:04:15,800 --> 00:04:17,240 is going to be even more challenging. 84 00:04:17,640 --> 00:04:20,440 So I think you can learn a lot of things. 85 00:04:21,129 --> 00:04:21,529 Yeah. 86 00:04:21,529 --> 00:04:25,529 So maybe let's actually just go way back in time instead of talk 87 00:04:25,529 --> 00:04:28,729 about Cryptococcus neoformans and. 88 00:04:28,809 --> 00:04:31,289 Or however one is meant to pronounce that properly. 89 00:04:31,449 --> 00:04:32,129 You got it. 90 00:04:32,129 --> 00:04:32,689 Oh, great. 91 00:04:32,689 --> 00:04:33,369 Fantastic. 92 00:04:33,369 --> 00:04:33,769 And. 93 00:04:33,849 --> 00:04:37,089 And so tell me a little bit about how, how you came to study 94 00:04:37,089 --> 00:04:40,169 that particular pathogenic yeast. 95 00:04:40,889 --> 00:04:41,289 Why. 96 00:04:41,609 --> 00:04:43,289 Why it's an important thing to study. 97 00:04:44,569 --> 00:04:45,529 Walk me back there? 98 00:04:45,769 --> 00:04:46,889 Yeah, absolutely. 99 00:04:47,609 --> 00:04:50,209 I think from my undergrad and my master's, that's where I studied 100 00:04:50,209 --> 00:04:52,009 Fusarium the AG. 101 00:04:52,790 --> 00:04:54,470 And then for my PhD, I wanted to shift. 102 00:04:54,470 --> 00:04:57,830 I still wanted to study fungi, but I wanted to look at the human 103 00:04:57,830 --> 00:04:59,350 relevant pathogens. 104 00:04:59,750 --> 00:05:03,430 And so at the University of British Columbia, Jim Cronstad was 105 00:05:03,430 --> 00:05:05,430 a researcher there studying Cryptococcus. 106 00:05:05,910 --> 00:05:07,750 There are not many fungal researchers. 107 00:05:07,750 --> 00:05:11,990 And so I reached out to him and I was very passionate about studying 108 00:05:11,990 --> 00:05:13,830 and so he invited me to join his lab. 109 00:05:14,470 --> 00:05:19,630 And I think it's an amazing pathogen because it's quite fascinating 110 00:05:19,630 --> 00:05:25,010 to study and it has global importance and relevance infections 111 00:05:25,010 --> 00:05:27,730 around the world and with immunocompromised individuals and 112 00:05:27,810 --> 00:05:28,530 kind of that. 113 00:05:28,690 --> 00:05:32,370 The dynamic, the importance and dynamic that the host health 114 00:05:32,530 --> 00:05:38,530 plays on whether the fungi is a Pathogen or not was a very intriguing 115 00:05:38,530 --> 00:05:39,410 question for me. 116 00:05:39,810 --> 00:05:43,730 And so that's what led me to study that pathogen. 117 00:05:44,210 --> 00:05:47,210 And then when I started my own lab, I was able to bring the two 118 00:05:47,210 --> 00:05:52,110 of them together in the sense that I'd say half or a third of my 119 00:05:52,110 --> 00:05:55,950 lab studies crop relevant fungal pathogens and then another 120 00:05:56,190 --> 00:05:59,470 two thirds studied the human relevant fungal pathogens. 121 00:05:59,470 --> 00:06:03,710 So I didn't set out to, you know, kind of have those two arms 122 00:06:03,710 --> 00:06:05,030 going within my research program. 123 00:06:05,030 --> 00:06:08,830 But it's worked out beautifully and it allows me to kind 124 00:06:08,830 --> 00:06:11,750 of keep the, all the things I found interesting along the way. 125 00:06:11,750 --> 00:06:13,150 I can keep going with them. 126 00:06:13,950 --> 00:06:14,590 That's great. 127 00:06:14,590 --> 00:06:17,550 Well, so maybe for those of us that are sort of new to this space, 128 00:06:18,270 --> 00:06:24,140 can you give me the headline kindergarten explanation of why and 129 00:06:24,140 --> 00:06:27,220 why we really need to understand host pathogen interactions 130 00:06:27,220 --> 00:06:32,100 and why studying host alone and pathogen alone isn't sufficient. 131 00:06:32,900 --> 00:06:35,380 I would say that it's really important for us. 132 00:06:35,380 --> 00:06:40,260 So each individual has their own immune system, their own way 133 00:06:40,260 --> 00:06:44,740 to respond to infections and the environment that surrounds them. 134 00:06:45,220 --> 00:06:47,340 And that's based on genetics. 135 00:06:47,340 --> 00:06:50,940 It's based on what you're exposed to on a daily basis, many 136 00:06:50,940 --> 00:06:51,780 different factors. 137 00:06:52,510 --> 00:06:54,750 And so a pathogen does not know that. 138 00:06:54,750 --> 00:06:57,310 A pathogen does not know what the host is going to be like. 139 00:06:57,310 --> 00:06:57,630 Right. 140 00:06:57,790 --> 00:07:02,270 It's not a relationship until they become together within the host 141 00:07:02,270 --> 00:07:02,670 environment. 142 00:07:03,150 --> 00:07:07,870 And so I think that's why is because each system is its own operating 143 00:07:08,430 --> 00:07:10,270 component separately. 144 00:07:10,670 --> 00:07:13,430 And when they come together, you can either fight it off and be 145 00:07:13,430 --> 00:07:17,190 healthy and get over a cold or, you know, get over an infection, 146 00:07:17,190 --> 00:07:20,110 because your body is built to do that or you don't. 147 00:07:20,430 --> 00:07:23,780 And for those that do not, then there's a lot of implications 148 00:07:24,170 --> 00:07:27,690 downstream and you know, healthcare costs and quality of life, 149 00:07:27,690 --> 00:07:31,530 compromise, compromising and compromisation. 150 00:07:32,090 --> 00:07:37,170 And so it's, I think, understanding that, you know, a pathogen 151 00:07:37,170 --> 00:07:39,770 is one aspect of the picture, the host is the other aspect. 152 00:07:40,010 --> 00:07:42,250 And when they come together, we don't know the answer. 153 00:07:42,330 --> 00:07:45,850 And each individual has a different mechanism or a different 154 00:07:45,850 --> 00:07:46,570 way to respond. 155 00:07:47,210 --> 00:07:50,510 And so that means that each, we can learn a lot from every, every 156 00:07:50,510 --> 00:07:52,870 individual's situation and response. 157 00:07:52,870 --> 00:07:56,910 And I believe that's part of why it's important to study both, 158 00:07:56,910 --> 00:08:00,110 because we can make treatments on a population basis, but if it 159 00:08:00,110 --> 00:08:02,430 doesn't work for one individual or one pathogen, it's 160 00:08:02,430 --> 00:08:03,390 not really that useful. 161 00:08:03,470 --> 00:08:08,030 And so we need to be able to understand in many different layers. 162 00:08:08,830 --> 00:08:09,950 That makes a lot of sense. 163 00:08:10,190 --> 00:08:16,280 One thing that I'd like to understand a little bit more is when 164 00:08:16,280 --> 00:08:17,520 you think about Pathogens. 165 00:08:17,520 --> 00:08:21,520 And I realize much of your work is on fungal pathogens, but 166 00:08:23,920 --> 00:08:30,080 what really is differentiating a pathogen from a helpful microbiota 167 00:08:30,400 --> 00:08:33,200 that is just part of our life? 168 00:08:33,840 --> 00:08:37,320 Yeah, it's a great question. 169 00:08:37,320 --> 00:08:40,000 And it really ties into that host pathogen interaction. 170 00:08:40,000 --> 00:08:40,280 Right? 171 00:08:40,280 --> 00:08:43,760 Because for Fusarium and Cryptococcus, they're not typically 172 00:08:43,760 --> 00:08:47,770 within the host, and so you can become colonized with them upon 173 00:08:47,770 --> 00:08:48,850 exposure from the environment. 174 00:08:49,330 --> 00:08:53,210 But if we consider bacteria within our gut, or fungi within our 175 00:08:53,210 --> 00:08:56,930 gut, or microbes on our skin, of course we're not constantly infected 176 00:08:56,930 --> 00:08:57,330 with them. 177 00:08:57,330 --> 00:08:58,530 So what is that trigger? 178 00:08:58,530 --> 00:09:03,370 And there is a lot of research that goes into understanding, you 179 00:09:03,370 --> 00:09:06,850 know, how do they survive together and how do they adapt, and 180 00:09:06,850 --> 00:09:08,210 when is that dysregulation. 181 00:09:08,770 --> 00:09:13,010 So one of the examples for fungal pathogens that I often think 182 00:09:13,010 --> 00:09:16,450 about is that if you're put on antibiotics for bacteria, bacterial 183 00:09:16,450 --> 00:09:19,210 infection, of course, then there might be side effects that 184 00:09:19,210 --> 00:09:19,610 come along. 185 00:09:19,610 --> 00:09:22,450 Oral thrush is a common one where you have yeast that are able 186 00:09:22,450 --> 00:09:24,850 to grow in the absence of bacteria. 187 00:09:25,010 --> 00:09:29,650 And it is a real, tangible observation of the competitiveness 188 00:09:29,730 --> 00:09:32,210 that goes on between microbes in our body. 189 00:09:32,610 --> 00:09:35,810 Those microbes exist all the time, and yet we do not have the 190 00:09:35,810 --> 00:09:37,410 symptoms the same way all the time. 191 00:09:37,490 --> 00:09:41,330 So it's this balance and it's disruption to that balance, and that's 192 00:09:41,330 --> 00:09:42,850 where you get the response. 193 00:09:43,170 --> 00:09:46,850 And hopefully within a healthy individual or an immunocompetent 194 00:09:46,850 --> 00:09:50,590 individual, your body can bring you back to that equilibrium. 195 00:09:50,670 --> 00:09:53,870 And again, each person has their unique equilibrium. 196 00:09:53,950 --> 00:09:58,510 So it's fascinating to study the interactions of microbes together 197 00:09:59,390 --> 00:10:03,190 and then that switch to a pathogenic phase and as well as how 198 00:10:03,190 --> 00:10:05,950 external factors like antibiotics can impact that. 199 00:10:06,430 --> 00:10:07,710 Yeah, that's really interesting. 200 00:10:07,790 --> 00:10:12,590 And how much, when we think about interactions on a macro scale, 201 00:10:12,830 --> 00:10:16,570 we're often talking about ecology, talking about, you know, 202 00:10:16,570 --> 00:10:19,210 large animals interacting with other large animals. 203 00:10:19,930 --> 00:10:24,490 How, how much, from your perspective, do those principles 204 00:10:24,570 --> 00:10:31,650 of ecology or systems ecology come out when studying these questions 205 00:10:31,650 --> 00:10:31,930 of. 206 00:10:32,330 --> 00:10:36,250 Of biota interactions, Biota host interactions. 207 00:10:37,770 --> 00:10:39,490 I think the. 208 00:10:39,490 --> 00:10:40,850 I want to go with the principle. 209 00:10:40,850 --> 00:10:41,370 So I. 210 00:10:41,690 --> 00:10:45,050 My research program is kind of is built around a one health concept. 211 00:10:45,130 --> 00:10:48,230 And when you talk about ecology and you talk macro scales, 212 00:10:48,230 --> 00:10:49,510 that's what comes to mind. 213 00:10:49,910 --> 00:10:52,670 Because the principle of one health is that you're looking at 214 00:10:52,670 --> 00:10:55,990 the interaction across human health, animal health, and the environment. 215 00:10:56,710 --> 00:11:00,390 And so you might be studying one microbe that is important for, 216 00:11:00,790 --> 00:11:04,350 you know, for a crop to thrive or within the soil, something like 217 00:11:04,350 --> 00:11:04,630 that. 218 00:11:04,870 --> 00:11:07,750 But how is that microbe impacted by the whole environment? 219 00:11:08,550 --> 00:11:11,110 And so that's what I think about when I think about ecology. 220 00:11:11,110 --> 00:11:15,230 And one of the examples that ties into the work we do is looking 221 00:11:15,230 --> 00:11:19,650 at fungicides that are applied in the field to prevent fungal infections 222 00:11:19,650 --> 00:11:21,010 of wheat, for example. 223 00:11:21,330 --> 00:11:23,810 Those fungicides then reset reside in the environment. 224 00:11:24,130 --> 00:11:27,370 And if we look at that on a grand scale, the microbes within 225 00:11:27,370 --> 00:11:29,730 the environment are exposed to those chemicals. 226 00:11:30,290 --> 00:11:35,410 And if it is a fungal microbe that is then, you know, infects a 227 00:11:35,410 --> 00:11:39,210 human, for example, we may be unable to treat it or it might be 228 00:11:39,210 --> 00:11:41,410 difficult to treat because it's already been exposed to these 229 00:11:41,410 --> 00:11:44,690 fungal drug or antifungal agents or, or fungicides. 230 00:11:45,090 --> 00:11:49,330 And so kind of that whole systems approach as to how, you know, 231 00:11:49,330 --> 00:11:51,990 something that we, that we do that apply to the field so we have 232 00:11:51,990 --> 00:11:55,710 better food and food security and safety can actually harm how 233 00:11:55,710 --> 00:11:57,870 we treat infections in the clinic. 234 00:11:58,110 --> 00:12:02,710 And that big picture concept is it's nice umbrella that helps 235 00:12:02,710 --> 00:12:06,350 us to stay with the vision of what we're doing and how important 236 00:12:06,430 --> 00:12:09,790 that minor discoveries in the lab can really have implications 237 00:12:10,110 --> 00:12:11,230 far beyond that. 238 00:12:11,390 --> 00:12:18,710 Now you had this really lovely paper in maybe 2023 on reviewing 239 00:12:18,710 --> 00:12:20,270 this concept of One Health. 240 00:12:20,430 --> 00:12:25,370 And so maybe walk us through a little bit where that concept emerged 241 00:12:25,370 --> 00:12:25,690 from. 242 00:12:26,410 --> 00:12:27,730 When did you first see it? 243 00:12:27,730 --> 00:12:29,210 How did you first interact with it? 244 00:12:31,210 --> 00:12:35,770 Yeah, I would like to say that it was intentional, but it was not. 245 00:12:36,810 --> 00:12:43,610 So what happened was, is that through my training, when I was studying 246 00:12:43,610 --> 00:12:48,050 agriculture health and fungal pathogens and agriculture and I bring 247 00:12:48,050 --> 00:12:52,050 that into my lab and then I'm studying human fungal pathogens in 248 00:12:52,050 --> 00:12:53,910 the clinical side and I brought that into the lab. 249 00:12:54,150 --> 00:12:58,590 It was very much so that I could pursue multiple avenues for 250 00:12:58,590 --> 00:12:59,030 funding. 251 00:12:59,590 --> 00:13:01,470 You can have industry partnerships. 252 00:13:01,470 --> 00:13:03,070 It was very strategic in that sense. 253 00:13:03,070 --> 00:13:03,470 But it. 254 00:13:03,470 --> 00:13:05,510 They were two very separate programs. 255 00:13:05,990 --> 00:13:10,550 And then being at Guelph One Health is a term that they really 256 00:13:10,550 --> 00:13:15,190 promote and advertise, but it's a very difficult to grasp term 257 00:13:15,350 --> 00:13:18,270 because a lot of people either feel excluded because they're not 258 00:13:18,270 --> 00:13:22,310 doing One Health research or it can be defined in like a million 259 00:13:22,390 --> 00:13:23,190 different ways. 260 00:13:23,590 --> 00:13:23,950 And. 261 00:13:23,950 --> 00:13:25,810 But that's also kind of the beauty of it. 262 00:13:26,130 --> 00:13:31,290 And so with the flagship and Guelph Calgary is also doing a lot 263 00:13:31,290 --> 00:13:31,970 of One Health. 264 00:13:32,050 --> 00:13:33,490 There's institutes in Switzerland. 265 00:13:33,490 --> 00:13:36,370 It's becoming more of a globally known term. 266 00:13:36,930 --> 00:13:40,490 And so when I was reading about it and this review kind of 267 00:13:40,490 --> 00:13:44,370 came up and we were looking at antifungal resistance and realized 268 00:13:44,370 --> 00:13:47,570 that these fungicides in the field, these azoles are what we use 269 00:13:47,570 --> 00:13:49,330 commonly to treat cryptococcal infection. 270 00:13:49,650 --> 00:13:52,690 And it was kind of this serendipitous aha moment that I was 271 00:13:52,690 --> 00:13:57,510 like, oh, my whole program can center around this one health umbrella. 272 00:13:57,670 --> 00:14:01,270 And, and I remember pitching that to some of my colleagues and 273 00:14:01,350 --> 00:14:03,670 they were like, oh, that's a good, that's a good idea. 274 00:14:03,670 --> 00:14:07,190 And I'm like yes, it is, isn't it? 275 00:14:07,190 --> 00:14:10,630 But it was, it was very much from the literature and, and reading 276 00:14:10,630 --> 00:14:14,270 what's been done and trying to find our own niche that, that it 277 00:14:14,270 --> 00:14:16,390 came about that that's. 278 00:14:16,390 --> 00:14:20,190 I love hearing these stories of serendipity because that there 279 00:14:20,190 --> 00:14:20,670 is so much. 280 00:14:20,670 --> 00:14:24,730 You're receiving inputs constantly and influencing your perspectives. 281 00:14:24,730 --> 00:14:27,730 And so this sounds like a place where you really were able 282 00:14:27,730 --> 00:14:32,650 to synthesize multiple inputs to come up with a really unique thesis. 283 00:14:33,370 --> 00:14:34,010 Thank you. 284 00:14:34,810 --> 00:14:36,170 I'd love to dive in. 285 00:14:37,690 --> 00:14:44,090 At the core of a lot of your research is proteomics as part of 286 00:14:44,090 --> 00:14:44,570 these studies. 287 00:14:44,570 --> 00:14:49,130 Even going back to that sort of first, some of your first work 288 00:14:49,130 --> 00:14:55,910 and I'm curious why you could, you could study any ohm you like, 289 00:14:55,990 --> 00:14:58,710 you could, you do in fact study many ohms together. 290 00:14:59,430 --> 00:15:03,310 But why did you choose to focus on proteomics in this space 291 00:15:03,310 --> 00:15:05,030 of host pathogen interactions? 292 00:15:05,270 --> 00:15:09,670 Yeah, I, I probably do a lot of self reflection on this question 293 00:15:09,750 --> 00:15:13,390 for, for some reason, I don't know why, but for some reason I often 294 00:15:13,390 --> 00:15:15,110 think like why proteomics? 295 00:15:15,590 --> 00:15:17,570 And I absolutely love it. 296 00:15:17,880 --> 00:15:18,520 And, and I. 297 00:15:18,520 --> 00:15:23,360 It's the technology, it's the discovery that goes with it, it's 298 00:15:23,360 --> 00:15:24,840 the computational advances. 299 00:15:24,920 --> 00:15:28,720 Like it's, it's just something that has really grasped, grasped 300 00:15:28,720 --> 00:15:30,600 me from the very beginning with research. 301 00:15:31,320 --> 00:15:34,240 And I remember I started doing 2D gels. 302 00:15:34,240 --> 00:15:38,360 That was the first introduction to Cardiomyx and they 303 00:15:38,360 --> 00:15:42,040 were so difficult and I remember like endless times washing 304 00:15:42,040 --> 00:15:45,160 the 2D gel plates and you'd come in the next morning when they're 305 00:15:45,160 --> 00:15:48,120 dry and they'd have like soap residue on them and you'd have to 306 00:15:48,120 --> 00:15:51,670 start all again and it would be a day and the electrophoresis 307 00:15:51,670 --> 00:15:53,670 wouldn't run properly, all these things. 308 00:15:53,670 --> 00:15:57,270 And when I think back to those days I'm like, why did I ever keep 309 00:15:57,270 --> 00:15:58,150 going with this? 310 00:15:58,150 --> 00:15:59,710 Like it doesn't make any sense. 311 00:16:00,430 --> 00:16:03,870 But I think it was the fact that I could tangibly see something 312 00:16:03,870 --> 00:16:08,510 on a screen like the dots from the 2D SCS page gels and then measure 313 00:16:08,510 --> 00:16:12,430 those on the mass spec and get an idea of what is going on biologically. 314 00:16:12,750 --> 00:16:16,220 It was the, it was that aha moment for me as a student because, 315 00:16:16,610 --> 00:16:20,410 because everything else had been textbook or in a lab where it's 316 00:16:20,410 --> 00:16:22,490 very set up for you. 317 00:16:22,490 --> 00:16:23,650 And the question is there. 318 00:16:23,890 --> 00:16:27,010 This was the first time that I was able to kind of discover on my 319 00:16:27,010 --> 00:16:27,330 own. 320 00:16:27,970 --> 00:16:31,650 And, and so I knew that no matter which questions I was asking 321 00:16:31,650 --> 00:16:35,410 or which pathogen or host system, proteomics was the technology 322 00:16:35,490 --> 00:16:37,730 that I wanted to, to use and apply. 323 00:16:38,130 --> 00:16:39,570 And that's, that's what I've done. 324 00:16:39,890 --> 00:16:40,330 Wow. 325 00:16:40,330 --> 00:16:41,250 No, that, that's great. 326 00:16:41,250 --> 00:16:44,950 It's amazing how these early choices can shape our, our path because 327 00:16:45,110 --> 00:16:47,590 it's possible that you might have, your very first technology 328 00:16:47,750 --> 00:16:51,710 might have been a fish assay or something like that, and then 329 00:16:51,710 --> 00:16:54,110 you would be doing transcriptomics for the rest of your 330 00:16:54,110 --> 00:16:54,390 life. 331 00:16:56,070 --> 00:16:56,630 Oh, no. 332 00:16:58,790 --> 00:17:02,630 Well, I guess just going down this theme, I'm curious, is there 333 00:17:02,630 --> 00:17:05,430 a question that you've encountered throughout your career 334 00:17:05,590 --> 00:17:07,670 where you look at it and you're like, you know what? 335 00:17:07,830 --> 00:17:13,600 If I had tried to answer this with doing genetic knockouts or looking 336 00:17:13,600 --> 00:17:17,280 at transcript, I wouldn't have been able to. 337 00:17:17,680 --> 00:17:21,360 The proteomics in particular was critical for answering this question. 338 00:17:23,040 --> 00:17:26,320 Well, I could say that about any project, especially if I'm writing 339 00:17:26,320 --> 00:17:33,000 a grant, that would be easy, but I would say so we use proteomics 340 00:17:33,000 --> 00:17:37,120 a lot for discovery in my lab and then we follow it up with a lot 341 00:17:37,120 --> 00:17:38,440 of biological findings. 342 00:17:38,440 --> 00:17:42,120 So genetic knockouts, as you say, sometimes we have to do RNA 343 00:17:42,120 --> 00:17:45,580 and QR codes, TPCR transcriptomics, it's not my favorite, 344 00:17:45,580 --> 00:17:50,060 but we do it sometimes to validate and see different aspects. 345 00:17:50,540 --> 00:17:54,860 And so for me, if we, if we don't get kind of a thread of interest, 346 00:17:55,100 --> 00:17:58,780 where to start with proteomics, then we change the research 347 00:17:58,860 --> 00:17:59,260 question. 348 00:17:59,820 --> 00:18:03,660 And that's because I think there's a lot of power there to, 349 00:18:03,660 --> 00:18:05,340 in looking at the proteins. 350 00:18:05,820 --> 00:18:09,860 But that being said, with some of our biggest studies, one recently 351 00:18:09,860 --> 00:18:11,660 we were looking at antifungal resistance. 352 00:18:12,570 --> 00:18:17,050 We also are very cautious to not say proteins are the most important 353 00:18:17,130 --> 00:18:18,330 or the only aspect. 354 00:18:18,650 --> 00:18:21,850 We also do whole genome sequencing on our different isolates. 355 00:18:22,410 --> 00:18:25,730 We may look at transcript changes across to see if it's a, 356 00:18:25,730 --> 00:18:28,650 you know, a consistent change in the protein or a post translational 357 00:18:28,650 --> 00:18:29,370 modification. 358 00:18:29,930 --> 00:18:34,850 So we're like always open to using complementary approaches to 359 00:18:34,850 --> 00:18:35,970 further our argument. 360 00:18:35,970 --> 00:18:38,570 And whether it be that the protein was the best way to do it 361 00:18:38,570 --> 00:18:43,780 or not, one of the most recent applications where proteomics really 362 00:18:43,780 --> 00:18:48,100 empowered our research, I would say, is, is a paper on the 363 00:18:48,100 --> 00:18:52,500 blood proteome and looking at diagnostic markers of cryptococcal 364 00:18:52,500 --> 00:18:52,940 infection. 365 00:18:53,660 --> 00:18:57,340 And we wouldn't be able to find that with with genomics or, 366 00:18:57,820 --> 00:18:59,100 or transcriptomics. 367 00:18:59,660 --> 00:19:03,380 And the idea of where we want to take this is into, you know, real 368 00:19:03,380 --> 00:19:07,900 world diagnostic approaches that are affordable and non invasive 369 00:19:08,140 --> 00:19:12,090 because right now a lot of them require spinal fluid taps and 370 00:19:12,090 --> 00:19:14,730 collection of cerebral spinal fluid to diagnose infection. 371 00:19:14,890 --> 00:19:19,530 So if we can use proteomics to identify potential proteins for an 372 00:19:19,530 --> 00:19:24,050 ELISA assay that we could apply, that would be really empowering 373 00:19:24,050 --> 00:19:28,290 for our, for our group, but also for how we detect the pathogen 374 00:19:28,290 --> 00:19:28,970 and the infection. 375 00:19:29,450 --> 00:19:32,330 Yeah, that's really, that's, that's a really powerful example. 376 00:19:32,810 --> 00:19:36,690 One of your earlier studies was looking at the secretome and 377 00:19:36,850 --> 00:19:41,170 that's often a place where transcript simply doesn't know what 378 00:19:41,170 --> 00:19:43,330 is secreted or how that's changed. 379 00:19:43,490 --> 00:19:49,690 And so I'd love to hear, you know, what is your favorite, your 380 00:19:49,690 --> 00:19:52,449 favorite study that you've done or like, wow. 381 00:19:55,730 --> 00:19:57,810 I understand that all the ohms are important. 382 00:19:57,810 --> 00:19:59,250 I'm a systems biologist also. 383 00:20:00,050 --> 00:20:02,290 However, every now and again you look at something and you're 384 00:20:02,290 --> 00:20:06,820 like, wow, that the protein was the key driver of X. 385 00:20:07,300 --> 00:20:11,220 And so I'd just love to hear what your favorite example of that 386 00:20:11,220 --> 00:20:11,540 is. 387 00:20:12,580 --> 00:20:13,340 That's a good question. 388 00:20:13,340 --> 00:20:14,740 It's like picking your favorite child. 389 00:20:14,900 --> 00:20:16,500 I know, it's very challenging. 390 00:20:16,580 --> 00:20:18,580 You do always have a favorite, so it's okay. 391 00:20:20,180 --> 00:20:24,980 I would say our recent story on antifungal resistance is probably 392 00:20:25,220 --> 00:20:30,340 the kind of the most exciting in a sense, but also like the most 393 00:20:30,340 --> 00:20:34,620 intriguing because antimicrobial resistance, antifungal 394 00:20:34,620 --> 00:20:38,260 resistance is often tied to genetic factors, the mutations in 395 00:20:38,260 --> 00:20:38,620 genes. 396 00:20:38,700 --> 00:20:41,380 And that is definitely a driving factor of it and how the 397 00:20:41,380 --> 00:20:46,660 pathogen evolves upon exposure to drugs, but it's not always the 398 00:20:46,660 --> 00:20:49,740 case and there's a lot of heterogeneity in resistance. 399 00:20:50,220 --> 00:20:53,940 So we wanted to use proteomics to look at antifungal resistance 400 00:20:53,940 --> 00:20:54,940 in Cryptococcus. 401 00:20:54,940 --> 00:20:59,180 And we identified, I think, six proteins that were higher in 402 00:20:59,180 --> 00:21:01,860 clinical isolate and our lab evolved isolate. 403 00:21:01,860 --> 00:21:06,360 And so that was a cool moment where I thought, like, this is neat. 404 00:21:06,360 --> 00:21:07,960 We never would have seen this. 405 00:21:08,520 --> 00:21:11,000 And it's also not consistent. 406 00:21:11,160 --> 00:21:15,440 So like a gene mutation stays once it's there, it usually stays 407 00:21:15,440 --> 00:21:16,760 unless it evolves differently. 408 00:21:17,480 --> 00:21:20,560 But the protein level would go up and down depending on exposure 409 00:21:20,560 --> 00:21:21,080 to the drug. 410 00:21:21,080 --> 00:21:25,240 And so it shows you the dynamics of a system and the dynamics 411 00:21:25,240 --> 00:21:26,280 of that resistance. 412 00:21:26,600 --> 00:21:30,120 And so we showed that if we inhibited the protein, we could actually 413 00:21:30,120 --> 00:21:32,680 reverse resistance, which was really cool. 414 00:21:33,080 --> 00:21:37,000 And we could turn it on and off so we could have the strain that's 415 00:21:37,160 --> 00:21:39,000 resistant inhibit the protein. 416 00:21:39,000 --> 00:21:39,880 Then it's Susceptible. 417 00:21:39,880 --> 00:21:42,240 And then we take, you know, change the media, it's growing in 418 00:21:42,240 --> 00:21:43,240 and now it's resistant. 419 00:21:43,240 --> 00:21:49,840 So just that new understanding and kind of that new idea of where 420 00:21:49,840 --> 00:21:51,480 proteins can really play a role. 421 00:21:52,280 --> 00:21:53,960 That's my favorite one so far. 422 00:21:54,440 --> 00:21:55,280 That's really amazing. 423 00:21:55,280 --> 00:21:58,400 And the dynamism, I think that's one of the aspects that's 424 00:21:58,400 --> 00:22:02,740 so special about the proteome is that it's, it operates at multiple 425 00:22:02,740 --> 00:22:04,020 different timescales. 426 00:22:04,980 --> 00:22:07,460 Things like truncations or degradations. 427 00:22:07,860 --> 00:22:14,100 PTMs are very fast and then you have turnover mediated things 428 00:22:14,100 --> 00:22:16,940 that require translating a protein and that can take a very 429 00:22:16,940 --> 00:22:19,820 long time for the signal to make it all the way back again. 430 00:22:19,820 --> 00:22:24,340 And so those cycles that you're describing or changes per 431 00:22:24,340 --> 00:22:28,500 environmental context, dependent behaviors are, are so neat 432 00:22:28,500 --> 00:22:30,300 when you see them in the proteome. 433 00:22:32,060 --> 00:22:37,780 I guess maybe carrying this on further, just thinking about you've 434 00:22:37,780 --> 00:22:40,220 done a lot of work in metabolomics and gene expression, 435 00:22:40,220 --> 00:22:41,260 et others. 436 00:22:43,019 --> 00:22:47,100 How do you think about integrating the different OHMs together? 437 00:22:48,220 --> 00:22:52,540 Every lab has their own style of way that they try to think about 438 00:22:52,540 --> 00:22:56,650 how the OHMs interplay, how they try to bridge the data. 439 00:22:57,450 --> 00:23:02,170 How do you integrate the diversity of omics technologies together? 440 00:23:03,690 --> 00:23:06,010 Yeah, it's challenging, right? 441 00:23:06,010 --> 00:23:09,090 And I think every lab that does systems biology or does that 442 00:23:09,090 --> 00:23:12,650 integration, as you said, has their own way of doing it and that's 443 00:23:12,650 --> 00:23:14,250 usually through a lot of trial and error. 444 00:23:14,650 --> 00:23:17,770 So you had mentioned the molecular farming study and that 445 00:23:17,770 --> 00:23:20,610 was one of the first ones where we integrated the two approaches. 446 00:23:20,610 --> 00:23:25,090 We had proteomics of the plant and then looking at metabolites as 447 00:23:25,090 --> 00:23:26,090 well that were produced. 448 00:23:27,110 --> 00:23:30,430 What was funny, not so funny for my PhD student, but kind of funny 449 00:23:30,430 --> 00:23:33,110 in hindsight is that, you know, we have the proteome and we 450 00:23:33,110 --> 00:23:34,790 can identify thousands of proteins. 451 00:23:34,790 --> 00:23:38,430 And he was like, oh, what happens when I get so many metabolites 452 00:23:38,430 --> 00:23:39,510 and I don't know what to follow up on. 453 00:23:39,510 --> 00:23:43,350 And I think in the end he got 14 that he was like looking at. 454 00:23:43,510 --> 00:23:46,750 And so we were both very deflated because we thought we're 455 00:23:46,750 --> 00:23:49,710 going to have this like keg map of all these pathways and we're 456 00:23:49,710 --> 00:23:50,950 going to do all this amazing stuff. 457 00:23:51,110 --> 00:23:55,270 And then he's like, I can just do this manually annotate it. 458 00:23:56,380 --> 00:24:00,300 So I think the reality of systems biology is immense and enormous 459 00:24:00,300 --> 00:24:03,340 and exciting or maybe the thought of it is. 460 00:24:03,420 --> 00:24:06,580 And then the reality of it is that it really comes down to your 461 00:24:06,580 --> 00:24:07,900 question and what you want to find. 462 00:24:08,060 --> 00:24:11,820 So for some things looking at one metabolite can be enough because 463 00:24:11,820 --> 00:24:15,420 it's A promising antifungal candidate that you want to pursue 464 00:24:15,900 --> 00:24:16,380 for others. 465 00:24:16,380 --> 00:24:19,460 You want to understand the whole pathway and how those compounds 466 00:24:19,460 --> 00:24:22,620 interact with others and that's much more dynamic. 467 00:24:22,780 --> 00:24:27,400 So I think bringing the two together is a very conscious thing 468 00:24:27,400 --> 00:24:29,120 that we do from the outset of a project. 469 00:24:29,440 --> 00:24:32,440 It's like we're going, this is going to be a metabolite focused 470 00:24:32,440 --> 00:24:35,400 project and we're going to complement it with proteomics or 471 00:24:35,400 --> 00:24:37,840 it's going to be proteomics all the way. 472 00:24:38,080 --> 00:24:40,080 And we're going to see if we get a compound that we're going to 473 00:24:40,080 --> 00:24:44,680 then test out and see what the diet, what the target is that helps 474 00:24:44,680 --> 00:24:47,280 us to bring them together in kind of a sensible way. 475 00:24:47,520 --> 00:24:53,230 Because otherwise it's, it is very challenging to mold it all together 476 00:24:53,230 --> 00:24:55,670 into a story that makes sense. 477 00:24:56,230 --> 00:25:01,270 Yeah, I'd love to double click on this aspect of molecular farming. 478 00:25:01,670 --> 00:25:06,710 Just how much can we do with molecular farming? 479 00:25:06,710 --> 00:25:07,670 Biopharming? 480 00:25:09,030 --> 00:25:09,510 Yes. 481 00:25:10,950 --> 00:25:12,550 I'm not an expert in the area. 482 00:25:12,790 --> 00:25:17,270 I would say this was a really neat opportunity to work with an 483 00:25:17,270 --> 00:25:18,310 industry partner. 484 00:25:18,310 --> 00:25:22,210 When I first started my position, they wanted do proteomics. 485 00:25:22,210 --> 00:25:25,250 And being new, I was like, yes, I can do that, no problem. 486 00:25:25,810 --> 00:25:29,730 And so we set up a project and it was a four or five year project, 487 00:25:29,810 --> 00:25:30,690 this collaboration. 488 00:25:30,690 --> 00:25:34,090 I had a PhD student working on it and it was not something I had 489 00:25:34,090 --> 00:25:34,850 ever explored before. 490 00:25:34,850 --> 00:25:36,610 I had no idea what they were doing. 491 00:25:36,610 --> 00:25:40,690 And the concept is, it's again taking this whole systems level approach 492 00:25:40,690 --> 00:25:45,330 in the ecosystem is that within the natural environment, agrobacterium 493 00:25:45,410 --> 00:25:49,350 bacteria infect plants, specific plants, and they cause these 494 00:25:49,350 --> 00:25:49,990 tumors. 495 00:25:50,230 --> 00:25:53,950 And that's by, they inject their own DNA into the host and then 496 00:25:53,950 --> 00:25:56,950 they have the host produce proteins that they need to survive. 497 00:25:57,430 --> 00:26:00,670 And so it's this, you know, fundamental concept that occurs in 498 00:26:00,670 --> 00:26:01,030 nature. 499 00:26:01,590 --> 00:26:04,590 And so there's scientists that are then harnessing this as we do 500 00:26:04,590 --> 00:26:07,670 for many different kind of scientific innovations. 501 00:26:08,470 --> 00:26:12,630 And so, but you could have a plant produce an antibody, for example, 502 00:26:12,630 --> 00:26:16,230 or a biologic or you know, another compound that you'd like. 503 00:26:16,870 --> 00:26:20,690 And within a plant system you also are not, you don't have the 504 00:26:20,690 --> 00:26:25,090 same considerations perhaps as with like I'm thinking lifestyle 505 00:26:25,090 --> 00:26:28,210 choices like veganism, for example, they may not want to use 506 00:26:28,450 --> 00:26:31,250 components that come from a cell system or an animal model. 507 00:26:31,410 --> 00:26:34,450 And so using the plant model, it's a, it's a different opportunity 508 00:26:34,450 --> 00:26:34,770 there. 509 00:26:35,170 --> 00:26:38,570 And so companies that are doing molecular farming, they want 510 00:26:38,570 --> 00:26:41,970 to produce an antibody injected into plants using a natural 511 00:26:42,370 --> 00:26:45,570 process of this bacteria infecting the plant. 512 00:26:45,570 --> 00:26:48,010 And then you collect the leaves, leaves extract it out, it's 513 00:26:48,010 --> 00:26:50,890 a very crude product and then you can purify it. 514 00:26:50,970 --> 00:26:54,810 And so we were using proteomics to kind of understand 515 00:26:54,970 --> 00:26:56,730 each level, each layer. 516 00:26:57,130 --> 00:26:59,490 So, you know, how's the best way to grow the bacteria? 517 00:26:59,490 --> 00:27:01,530 What happens when you infect the plant? 518 00:27:01,530 --> 00:27:04,450 Which, how do the bacteria respond and then how much product 519 00:27:04,450 --> 00:27:05,530 do you get at the end? 520 00:27:05,530 --> 00:27:07,690 But how could you improve that output? 521 00:27:07,850 --> 00:27:12,010 And that was our question with the paper was really can we help 522 00:27:12,010 --> 00:27:14,730 companies improve their molecular farming pipeline and get 523 00:27:14,730 --> 00:27:15,830 better yield fields? 524 00:27:16,070 --> 00:27:20,790 And so we identified proteases from the plant that actually degrade 525 00:27:20,790 --> 00:27:22,070 the target antibody. 526 00:27:22,790 --> 00:27:24,470 So we showed just a proof of principle. 527 00:27:24,470 --> 00:27:28,190 It was a very early study for us to show if we knock down these 528 00:27:28,190 --> 00:27:31,229 proteases or one in particular, then there's more antibody 529 00:27:31,229 --> 00:27:31,750 produced. 530 00:27:31,910 --> 00:27:35,710 And the particular example was a breast cancer drug. 531 00:27:35,710 --> 00:27:38,590 Trastuzumab is the one that they were, the company was using 532 00:27:38,590 --> 00:27:39,590 as their flagship. 533 00:27:40,070 --> 00:27:45,350 So it was such a neat way to, you know, kind of look at this natural 534 00:27:45,350 --> 00:27:45,830 infection. 535 00:27:45,830 --> 00:27:47,790 But then how can we use it for health? 536 00:27:48,670 --> 00:27:51,910 That I had never, I wasn't aware of before this opportunity. 537 00:27:51,910 --> 00:27:52,910 It seems miraculous. 538 00:27:52,910 --> 00:27:53,870 I and I. 539 00:27:53,870 --> 00:27:56,670 One of the things that really stood out for me in the paper was 540 00:27:56,670 --> 00:28:02,990 that flask grown versus bioreactor grown bacteria actually 541 00:28:03,630 --> 00:28:09,070 had an impact on the, on the plant uptake behavior. 542 00:28:10,080 --> 00:28:12,640 Yeah, it was really cool, isn't it? 543 00:28:13,120 --> 00:28:17,120 It's so neat because you like the bacteria are primed to infect 544 00:28:17,120 --> 00:28:18,680 if they're growing in the bioreactor. 545 00:28:18,680 --> 00:28:21,520 So it's this neat idea that they're ready. 546 00:28:21,680 --> 00:28:24,200 So when you put them in the plant, they just go for it and they 547 00:28:24,200 --> 00:28:25,759 can do the infection really quick. 548 00:28:25,840 --> 00:28:30,040 And yeah, it's not something I'd ever thought you'd see a difference 549 00:28:30,040 --> 00:28:33,040 of and how proteomics would allow us to see that difference. 550 00:28:33,760 --> 00:28:37,240 It was very discovery and neat to see. 551 00:28:37,480 --> 00:28:37,960 Yeah. 552 00:28:38,760 --> 00:28:42,600 I mean, naively it makes sense post facto that these environmental 553 00:28:42,600 --> 00:28:44,120 factors change the proteome. 554 00:28:44,120 --> 00:28:45,720 We see that in cancer all the time. 555 00:28:45,960 --> 00:28:53,240 But in a bioreactor environment is different than how 556 00:28:53,560 --> 00:28:55,080 pathogens might grow naturally. 557 00:28:55,400 --> 00:28:57,080 Microbes might grow naturally. 558 00:28:57,160 --> 00:29:02,810 So I wonder also if there are other forces beyond what's secreted. 559 00:29:03,130 --> 00:29:08,490 Maybe there are even things like density based effects, mechanical 560 00:29:09,210 --> 00:29:11,930 effects that drive those changes in behavior. 561 00:29:13,290 --> 00:29:14,090 Absolutely. 562 00:29:14,170 --> 00:29:16,850 And we only studied a few of them. 563 00:29:16,850 --> 00:29:17,210 Right. 564 00:29:17,690 --> 00:29:20,570 We had a very specific bioreactor system and then a specific 565 00:29:20,570 --> 00:29:23,050 flask system and just compared a few parameters. 566 00:29:23,050 --> 00:29:27,290 But you could absolutely expand it and the size of the bioreactor 567 00:29:27,290 --> 00:29:28,170 would also likely. 568 00:29:28,740 --> 00:29:28,860 Right. 569 00:29:28,860 --> 00:29:30,780 Because then you have different quorum sensing and all 570 00:29:30,780 --> 00:29:32,020 different components. 571 00:29:32,020 --> 00:29:34,420 So yeah, there's a lot, a lot to be done. 572 00:29:34,660 --> 00:29:35,540 That's really neat. 573 00:29:35,540 --> 00:29:38,180 Well, so I'd like to change gears a little bit. 574 00:29:38,180 --> 00:29:43,380 We've talked about different ohms and proteomics and I'd like 575 00:29:43,380 --> 00:29:44,619 to put you on the spot a little. 576 00:29:44,619 --> 00:29:48,180 And the technologies we have today are amazing and they're powerful. 577 00:29:48,180 --> 00:29:53,220 But what is something that you wish you could do with your available 578 00:29:53,380 --> 00:29:59,320 platforms that you can't do today or that is hard, hard today? 579 00:29:59,720 --> 00:30:00,280 Yeah. 580 00:30:00,360 --> 00:30:00,840 Yes. 581 00:30:01,400 --> 00:30:05,640 I think one of the biggest things would be accessibility of 582 00:30:05,640 --> 00:30:06,520 instrumentation. 583 00:30:07,320 --> 00:30:09,920 So if I think about, for my own lab and you think about buying 584 00:30:09,920 --> 00:30:12,640 a mass spectrometer and you know, state of the art mass spectrometer 585 00:30:12,640 --> 00:30:16,880 and you're spending a lot of money on these instruments, the odds 586 00:30:16,880 --> 00:30:20,520 of having an undergraduate student being able to use that instrument 587 00:30:20,520 --> 00:30:23,240 or even a grad student being able to use it are very low. 588 00:30:24,480 --> 00:30:29,600 And I know for myself, I did not have hands on, on a mass spectrometer 589 00:30:29,600 --> 00:30:30,960 until I was in my postdoc. 590 00:30:31,280 --> 00:30:34,240 And so I learned so much within the first week and I gained 591 00:30:34,240 --> 00:30:37,920 so much confidence and more knowledge of how things were working 592 00:30:37,920 --> 00:30:43,280 and what a peptide actually meant in that week than, than I had 593 00:30:43,280 --> 00:30:43,760 in years. 594 00:30:44,000 --> 00:30:46,480 And it was because I could actually touch the instrument, change 595 00:30:46,480 --> 00:30:49,160 the capillary, you know, understand when things were really 596 00:30:49,160 --> 00:30:50,860 hot, like a simple stuff stuff. 597 00:30:51,260 --> 00:30:54,340 But, but that's really hard when we have instruments that are 598 00:30:54,340 --> 00:30:58,380 so expensive and that puts a lot of pressure on them operating 599 00:30:58,380 --> 00:30:59,020 all the time. 600 00:30:59,340 --> 00:31:02,460 And so I think it would be nice to have, you know, you buy a 601 00:31:02,460 --> 00:31:06,220 big new shiny instrument and then you get like an older model 602 00:31:06,379 --> 00:31:08,900 that would be for testing and for training. 603 00:31:08,900 --> 00:31:10,460 And it's like a two for one. 604 00:31:10,460 --> 00:31:11,060 That would be. 605 00:31:11,060 --> 00:31:15,300 What I would ask for is so that you can actually have everyone 606 00:31:15,300 --> 00:31:18,250 in your lab, hands on training, training on that piece 607 00:31:18,250 --> 00:31:21,370 of equipment so when they want to go get a job at a company, they 608 00:31:21,370 --> 00:31:24,850 can say, I've worked on your mass spec before, that would be really 609 00:31:24,850 --> 00:31:25,570 empowering. 610 00:31:25,970 --> 00:31:27,410 Yeah, no, that's really interesting. 611 00:31:27,410 --> 00:31:29,930 That's a, that's an aspect of the conversation that doesn't come 612 00:31:29,930 --> 00:31:34,570 up very often, which is just the accessibility of the tools and 613 00:31:34,570 --> 00:31:36,370 availability of the tools. 614 00:31:36,690 --> 00:31:39,930 And I'm curious actually just to go a little bit deeper there because 615 00:31:39,930 --> 00:31:44,490 you mentioned as you got hands on with the mass spectrometer, it 616 00:31:44,490 --> 00:31:48,410 changed your understanding of the workflow and process of proteomics. 617 00:31:48,810 --> 00:31:50,450 Can you just say a little bit more about that? 618 00:31:50,450 --> 00:31:53,650 Because I think this is a place where oftentimes people coming 619 00:31:53,650 --> 00:31:57,970 from other domains, their assumption is, okay, well, you walk 620 00:31:57,970 --> 00:32:00,490 up, you press go, and proteome comes out. 621 00:32:00,810 --> 00:32:03,290 And that's not actually what happens. 622 00:32:03,450 --> 00:32:06,410 And there's a lot of detail and understanding. 623 00:32:06,410 --> 00:32:10,900 And so I'd love to just go to that moment in your life where you 624 00:32:10,900 --> 00:32:14,340 weren't reliant on other, other folks as much and you were 625 00:32:15,140 --> 00:32:17,300 there face to face with the instrumentation yourself. 626 00:32:18,740 --> 00:32:20,180 And you're absolutely right. 627 00:32:20,180 --> 00:32:24,020 It has a huge role in, you know, how I see things and how I 628 00:32:24,020 --> 00:32:27,860 do things, how I teach now, whether it be, you know, at the instrument 629 00:32:27,860 --> 00:32:28,980 or it's theoretical. 630 00:32:29,860 --> 00:32:33,180 Because when I didn't have access to the instrument, it was 631 00:32:33,180 --> 00:32:34,340 very much a black box. 632 00:32:34,340 --> 00:32:38,060 And I never thought that I would be able to understand it. 633 00:32:38,140 --> 00:32:41,020 I never thought that I'd be able to explain it or know what's 634 00:32:41,020 --> 00:32:41,500 going on. 635 00:32:41,580 --> 00:32:44,140 And it's not because people wouldn't teach me, but it was because 636 00:32:44,140 --> 00:32:46,460 I had no visual connection to it. 637 00:32:46,940 --> 00:32:50,220 So I remember early studies you mentioned about the secretome 638 00:32:50,540 --> 00:32:54,020 and there were some aspects of targeted proteomics in that, in that 639 00:32:54,020 --> 00:32:54,340 assay. 640 00:32:54,340 --> 00:32:57,620 And I remember we were supposed to look at quadruples, but 641 00:32:57,620 --> 00:32:58,820 it meant nothing to me. 642 00:32:58,820 --> 00:32:59,100 Right. 643 00:32:59,100 --> 00:33:01,100 And, and these peaks, they meant nothing. 644 00:33:01,100 --> 00:33:05,670 And so it wasn't until my, yeah, my first week during my postdoc 645 00:33:05,670 --> 00:33:08,710 when I was actually allowed to clean an instrument that I saw a 646 00:33:08,710 --> 00:33:11,630 quadrupole and I was like, oh my goodness, it's exactly what it 647 00:33:11,630 --> 00:33:13,870 looks like in the images and this is how it works. 648 00:33:13,870 --> 00:33:15,870 And it really helped it click. 649 00:33:16,270 --> 00:33:20,830 And I think that it works on both sides because yes, it's a very 650 00:33:21,230 --> 00:33:24,590 high end instrument and proteomics does require expertise 651 00:33:24,990 --> 00:33:25,870 to some level. 652 00:33:26,190 --> 00:33:29,150 But really anyone can gain that expertise. 653 00:33:29,630 --> 00:33:32,750 And especially now instruments are very automated. 654 00:33:33,230 --> 00:33:37,050 So it can be a push this button, but you still want to know 655 00:33:37,530 --> 00:33:39,130 how it's working and what it's doing. 656 00:33:39,610 --> 00:33:44,370 And I think the other aspect of that is the mass spectra, the 657 00:33:44,370 --> 00:33:47,410 de novo sequencing and understanding what a mass spectra 658 00:33:47,410 --> 00:33:47,690 is. 659 00:33:48,810 --> 00:33:53,210 That's always been a very amazing aha moment for me when it 660 00:33:53,210 --> 00:33:56,250 came to mass spectrometry is it's like these peaks and what do 661 00:33:56,250 --> 00:33:56,570 they mean? 662 00:33:56,570 --> 00:33:58,090 And you can actually interpret it. 663 00:33:58,090 --> 00:34:03,130 So I think empowerment training, all of those aspects really 664 00:34:03,130 --> 00:34:07,210 make proteomics more appealing to more people if they know they 665 00:34:07,210 --> 00:34:07,730 can do it. 666 00:34:08,130 --> 00:34:09,890 Yeah, that makes great sense. 667 00:34:09,970 --> 00:34:13,850 And maybe just one more digging in a little bit deeper here 668 00:34:13,850 --> 00:34:14,250 as well. 669 00:34:14,250 --> 00:34:17,290 Just about the data that you're able to produce, the questions 670 00:34:17,290 --> 00:34:21,330 you're able to ask, where are the boundaries of there if you could 671 00:34:21,410 --> 00:34:28,610 invent your magical perfect system to answer questions that you're 672 00:34:28,610 --> 00:34:30,130 like today, it's just difficult. 673 00:34:31,950 --> 00:34:34,270 What would, what would that be able to do that you can't do today? 674 00:34:36,590 --> 00:34:41,750 What is difficult now is probably the entire pipeline. 675 00:34:41,750 --> 00:34:44,390 Like, so if I'm thinking about drug discovery, for example, and 676 00:34:44,390 --> 00:34:47,310 if I think about all the different layers that we use in my 677 00:34:47,310 --> 00:34:50,430 lab and all the different aspects and so if you use like computational 678 00:34:50,830 --> 00:34:54,310 ways to predict or design drugs and then you want to synthesize 679 00:34:54,310 --> 00:34:57,640 them and produce them in the lab and, and kind of each of those 680 00:34:57,640 --> 00:34:59,360 is its own individual piece. 681 00:34:59,520 --> 00:35:03,680 But it would be really neat to have it all together in one workflow 682 00:35:04,000 --> 00:35:08,480 and have it so that it's like a given, it's like an automated system, 683 00:35:08,480 --> 00:35:11,400 right, where you have this amazing mass spectrometer, you have 684 00:35:11,400 --> 00:35:14,960 your data analysis tools, you've got the upstream, the downstream 685 00:35:14,960 --> 00:35:16,400 all together in a pipeline. 686 00:35:16,720 --> 00:35:21,600 And that is my kind of dream of what I would like to build and 687 00:35:22,000 --> 00:35:22,800 incorporate. 688 00:35:23,280 --> 00:35:26,950 That would all of the little barriers that exist in each of those 689 00:35:26,950 --> 00:35:29,110 pieces would no longer be there. 690 00:35:29,190 --> 00:35:30,070 It would be one. 691 00:35:30,710 --> 00:35:32,630 Yeah, just a whole integrated. 692 00:35:33,430 --> 00:35:35,590 I think that's definitely something that we've seen in our 693 00:35:35,590 --> 00:35:38,670 lab as well, is that there is a lot of domain knowledge that's 694 00:35:38,670 --> 00:35:39,190 required. 695 00:35:40,390 --> 00:35:45,990 Switching from X tandem to pick your favorite sequence analysis 696 00:35:45,990 --> 00:35:49,700 tool, they each behave just a little bit differently. 697 00:35:50,170 --> 00:35:54,410 And so understanding how they connect together, there are a lot 698 00:35:54,410 --> 00:35:58,410 of little places where they're just tiny little friction points 699 00:35:58,410 --> 00:36:02,690 along the way that sort of coalesce into adding up into barriers 700 00:36:02,690 --> 00:36:05,770 to having more and more people joining us in the field and saying, 701 00:36:05,930 --> 00:36:08,490 yes, proteomics is a go to tool for me. 702 00:36:08,650 --> 00:36:10,250 Switching gears entirely. 703 00:36:10,810 --> 00:36:13,850 Let's talk about Hupo and then I want to talk about moms and proteomics. 704 00:36:14,650 --> 00:36:18,610 What are you most excited about hupo that your lab is going 705 00:36:18,610 --> 00:36:20,670 to be sharing with with the rest of the world? 706 00:36:20,750 --> 00:36:22,270 This, this conference. 707 00:36:23,470 --> 00:36:25,390 So I'm very excited for HUPO to get started. 708 00:36:26,110 --> 00:36:30,190 It's a lot of meetings in preparation for it and a lot of anticipation 709 00:36:30,510 --> 00:36:31,950 of the conference itself. 710 00:36:32,910 --> 00:36:36,990 One of the most exciting things is that I have multiple people 711 00:36:36,990 --> 00:36:41,150 from my group coming from the agriculture health aspect, which 712 00:36:41,150 --> 00:36:44,350 they would typically not ever go to Hupo and I would not think 713 00:36:44,350 --> 00:36:45,870 to send them to hupo. 714 00:36:45,950 --> 00:36:49,870 We have different conference proteomics, plant proteomic conferences 715 00:36:49,870 --> 00:36:54,280 that they would go to and more biologically relevant agriculture 716 00:36:54,280 --> 00:36:55,160 ones. 717 00:36:55,400 --> 00:36:59,360 And so I'm super excited of the breadth that HUPO is bringing 718 00:36:59,360 --> 00:37:03,000 this year with and we have the theme One Health powered by Proteomics, 719 00:37:03,400 --> 00:37:08,600 but really having that take effect and come to play, where you 720 00:37:08,600 --> 00:37:12,080 have sessions dedicated to environmental health and session 721 00:37:12,080 --> 00:37:16,480 to clinical health, the integration with veterinary and animal 722 00:37:16,480 --> 00:37:19,830 health as well, and making sure that everyone still feels like 723 00:37:19,830 --> 00:37:23,270 it is Hupo and that it's the Hupo they know and love. 724 00:37:23,830 --> 00:37:26,950 But we're also bringing in new aspects and new people, and I think 725 00:37:26,950 --> 00:37:28,310 that's super exciting. 726 00:37:28,950 --> 00:37:29,710 That's really neat. 727 00:37:29,710 --> 00:37:33,750 I mean, expanding the tent to your point earlier, all these things 728 00:37:33,750 --> 00:37:39,110 that live in agriculture affect humans and vice versa. 729 00:37:39,110 --> 00:37:43,070 So that concept of bringing these pieces together is definitely 730 00:37:43,070 --> 00:37:47,230 a really exciting one and an opportunity also because it's closer 731 00:37:47,230 --> 00:37:48,560 to your backyard this year here. 732 00:37:49,040 --> 00:37:49,920 Yeah, for sure. 733 00:37:50,880 --> 00:37:55,120 And I guess are there other stories from other labs that you've 734 00:37:55,120 --> 00:37:59,000 heard snippets of that you, you're hoping to see more of at HUPO 735 00:37:59,000 --> 00:37:59,440 this year? 736 00:38:00,640 --> 00:38:02,800 I think definitely the computational side. 737 00:38:03,200 --> 00:38:07,120 Last year at Hupo, those rooms were not even standing room only. 738 00:38:07,120 --> 00:38:08,560 They were out the door only. 739 00:38:09,120 --> 00:38:12,720 So I think the hearing the latest of what people are doing with 740 00:38:12,720 --> 00:38:17,190 computational platforms and AI, of course, there's different 741 00:38:17,910 --> 00:38:23,270 chat bots now and agents that are supporting proteomics analysis 742 00:38:23,270 --> 00:38:24,470 and visualization. 743 00:38:24,630 --> 00:38:29,630 So that side of it, I think is really cool and I'm definitely looking 744 00:38:29,630 --> 00:38:32,870 forward to seeing that and also having my students see the components 745 00:38:32,870 --> 00:38:34,070 that are, that are changing. 746 00:38:34,790 --> 00:38:40,150 And the other aspect I would say is being able to kind of showcase 747 00:38:40,150 --> 00:38:44,660 the breadth of what's in the technology of where things are at 748 00:38:44,660 --> 00:38:47,340 and where they've been, where companies are going, you know, pushing 749 00:38:47,340 --> 00:38:47,940 the limits. 750 00:38:48,420 --> 00:38:52,540 So I like, I enjoy going to the, the sessions as well, by sponsors 751 00:38:52,540 --> 00:38:56,140 and industry partners, so that you really get to see like, what 752 00:38:56,140 --> 00:38:59,060 is happening at the next stage and what can we look forward to? 753 00:38:59,380 --> 00:39:00,260 Yeah, that's great. 754 00:39:00,260 --> 00:39:05,100 Well, and just Hupo is such a distinctive meeting for, for you. 755 00:39:05,100 --> 00:39:06,660 What is it that you like about hupo? 756 00:39:06,660 --> 00:39:09,220 What's your, what's your favorite part about it as a conference? 757 00:39:09,220 --> 00:39:10,640 There are so many conferences in the world. 758 00:39:10,710 --> 00:39:10,830 World. 759 00:39:10,830 --> 00:39:11,590 Why is Hupo. 760 00:39:12,470 --> 00:39:15,310 Yeah, and, and each conference has its own place for sure. 761 00:39:15,310 --> 00:39:16,030 In its own. 762 00:39:16,030 --> 00:39:20,310 You know, I think with Hupo, it's the fact that it is a large 763 00:39:20,310 --> 00:39:20,790 conference. 764 00:39:20,790 --> 00:39:23,070 It's our, you know, our largest proteomics conference that 765 00:39:23,070 --> 00:39:24,310 we have globally. 766 00:39:24,390 --> 00:39:26,230 And yet it feels like a small meeting. 767 00:39:26,709 --> 00:39:29,910 You, you know, it's a very connected network, very collaborative. 768 00:39:30,150 --> 00:39:32,590 You get to see friends, you get to see colleagues from all over 769 00:39:32,590 --> 00:39:33,030 the world. 770 00:39:33,270 --> 00:39:36,390 I love that it's so international that it rotates across 771 00:39:36,390 --> 00:39:40,100 the regions that you have, have so much it's so consciously 772 00:39:40,260 --> 00:39:43,540 diverse and that's not something that we typically see. 773 00:39:43,540 --> 00:39:47,540 And it, so it exposes you to all different science and researchers 774 00:39:47,860 --> 00:39:52,420 and also gets feedback on your own science and exposes what you're 775 00:39:52,420 --> 00:39:53,140 doing to the world. 776 00:39:53,860 --> 00:39:55,780 So just a great platform. 777 00:39:56,580 --> 00:40:00,340 My last question in this line for you is about Moms and Proteomics. 778 00:40:00,740 --> 00:40:04,300 For folks who aren't familiar, what is Moms and Proteomics? 779 00:40:04,300 --> 00:40:05,300 Where did it come from? 780 00:40:06,010 --> 00:40:09,650 And, and then I'd love to hear more about what Moms and Proteomics 781 00:40:09,650 --> 00:40:11,290 has planned at Hoopoe. 782 00:40:11,450 --> 00:40:12,490 Yes, for sure. 783 00:40:13,210 --> 00:40:17,050 Moms and Proteomics is an international initiative and now 784 00:40:17,050 --> 00:40:18,170 an international community. 785 00:40:19,050 --> 00:40:23,330 We have close to 250 members from around the world and it's very 786 00:40:23,330 --> 00:40:26,530 much dedicated to supporting and recognizing mothers and women 787 00:40:26,530 --> 00:40:27,210 in STEM. 788 00:40:28,250 --> 00:40:31,450 And it came about actually from Hupo 2021. 789 00:40:31,610 --> 00:40:35,400 There was a call for hot topics in proteomics. 790 00:40:35,800 --> 00:40:38,640 And at the time we were coming out of the pandemic and I had two 791 00:40:38,640 --> 00:40:41,160 young children at home and I was like, you know, what's a hot 792 00:40:41,160 --> 00:40:41,640 topic? 793 00:40:41,880 --> 00:40:43,680 Caring for children while being an academic. 794 00:40:43,680 --> 00:40:44,800 That's a hot topic. 795 00:40:44,800 --> 00:40:47,480 And, and being a mom and trying to navigate everything. 796 00:40:47,560 --> 00:40:53,640 And so I pitched this idea to, to the workshops and they were like, 797 00:40:55,720 --> 00:40:58,400 we were thinking like technology and things and I was like, 798 00:40:58,400 --> 00:41:00,050 trust me me, we can, we can do this. 799 00:41:00,050 --> 00:41:04,290 And, and so they really gave me that first opportunity to build 800 00:41:04,290 --> 00:41:05,810 it into something and showcase it. 801 00:41:05,810 --> 00:41:09,410 So it was very much a grassroots, bottom up community building. 802 00:41:09,970 --> 00:41:14,130 And since then it's, it's, I've had different events, different 803 00:41:14,130 --> 00:41:14,649 activities. 804 00:41:14,649 --> 00:41:17,970 We actually had a virtual coffee networking event this morning 805 00:41:18,610 --> 00:41:22,290 and, and now at Hupo, it's part of the program and every year 806 00:41:22,290 --> 00:41:24,490 we have different sessions. 807 00:41:24,490 --> 00:41:28,010 And so this year I'm very excited we have our first time, we're 808 00:41:28,010 --> 00:41:32,140 bringing in an invited speaker to discuss resilience building and 809 00:41:32,700 --> 00:41:36,860 inclusion within the mass spec, the proteomics biology community. 810 00:41:37,980 --> 00:41:43,340 So it's on the program I think for Tuesday included with registration 811 00:41:43,660 --> 00:41:46,380 and I think I'm really looking forward to it. 812 00:41:46,620 --> 00:41:51,220 Oh, that's so exciting and very inspirational that you had this 813 00:41:51,220 --> 00:41:54,180 notion and were able to bring it into the world and now it's a 814 00:41:54,180 --> 00:41:54,940 thriving community. 815 00:41:55,100 --> 00:42:00,310 That's, that's, I think that speaks volumes also just about how 816 00:42:00,310 --> 00:42:04,230 welcoming the proteomics community is to new ideas and that 817 00:42:04,230 --> 00:42:07,350 you can say, you know what, hey, this is hot, let's do this. 818 00:42:08,310 --> 00:42:12,230 And it's a huge important part of the conference. 819 00:42:12,230 --> 00:42:15,670 So for people who haven't been there, it really has become a very 820 00:42:15,670 --> 00:42:22,070 central part of Hupo and something that I'm so delighted is 821 00:42:22,070 --> 00:42:22,710 supported. 822 00:42:23,270 --> 00:42:28,330 My last question for you is really very forward looking and I'd 823 00:42:28,330 --> 00:42:30,010 like you to put on your future. 824 00:42:30,410 --> 00:42:35,690 Future you hat and you're 10 years from now, 20 years from now. 825 00:42:35,930 --> 00:42:37,890 What is the thing that you look at? 826 00:42:37,890 --> 00:42:41,450 Then you're like, okay, this is what I've learned, this is what 827 00:42:41,450 --> 00:42:42,570 I've been able to accomplish. 828 00:42:42,809 --> 00:42:45,130 This is how proteomics has shaped my world. 829 00:42:46,170 --> 00:42:51,650 Yeah, I think looking into the future, I would like to, you know, 830 00:42:51,650 --> 00:42:53,930 in all of our grants, when we write, you know, we're going to change 831 00:42:53,930 --> 00:42:55,450 the world, we're going to make a difference. 832 00:42:56,240 --> 00:42:59,680 I would like that to actually be true and not just be a statement 833 00:42:59,680 --> 00:43:04,840 that I include the last line and really translate some of our 834 00:43:04,840 --> 00:43:08,720 early findings into tangible applications. 835 00:43:09,040 --> 00:43:12,560 And whether that be in the agriculture field or whether it be 836 00:43:12,560 --> 00:43:17,560 in the clinic, entrepreneurial startup company and supporting my 837 00:43:17,560 --> 00:43:20,760 students through that journey as well because many of them are 838 00:43:20,760 --> 00:43:23,640 very interested and passionate in industry and translation knowledge. 839 00:43:23,640 --> 00:43:24,080 Translation. 840 00:43:24,850 --> 00:43:29,490 And so I think looking forward that, yeah, moving things from discovery 841 00:43:30,210 --> 00:43:35,610 into where we actually produce it or we provide this translatable 842 00:43:35,610 --> 00:43:41,330 application, that would be the probably the most rewarding component. 843 00:43:42,370 --> 00:43:45,330 Well, I look forward to seeing that come into reality. 844 00:43:45,970 --> 00:43:50,330 I totally believe that is coming and we're seeing it all over 845 00:43:50,330 --> 00:43:51,330 the place throughout our community. 846 00:43:52,710 --> 00:43:53,830 Thank you again so much. 847 00:43:53,830 --> 00:43:54,830 This has been so much fun. 848 00:43:54,830 --> 00:43:57,350 I'm really grateful that you were able to join us today. 849 00:43:57,910 --> 00:43:58,630 That's wonderful. 850 00:43:58,630 --> 00:43:59,110 Thank you. 851 00:43:59,110 --> 00:44:00,310 I really appreciate it. 852 00:44:03,190 --> 00:44:06,910 We hope you enjoyed the Translating Proteomics podcast brought 853 00:44:06,910 --> 00:44:08,950 to you by Nautilus Biotechnology. 854 00:44:09,510 --> 00:44:13,510 To contact us or for further information, Please email translating 855 00:44:13,510 --> 00:44:15,830 Proteomicsautilus.Bio.